{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:12:05Z","timestamp":1790223125110,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T00:00:00Z","timestamp":1258502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2288-9-77","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T00:07:41Z","timestamp":1258589261000},"source":"Crossref","is-referenced-by-count":27,"title":["International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC Study)"],"prefix":"10.1186","volume":"9","author":[{"given":"Juergen C","family":"Dinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Bardenheuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Assmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,18]]},"reference":[{"key":"393_CR1","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","volume":"346","author":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1995","unstructured":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet. 1995, 346: 1582-8.","journal-title":"Lancet"},{"key":"393_CR2","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","volume":"346","author":"H Jick","year":"1995","unstructured":"Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C: Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 1995, 346: 1589-93. 10.1016\/S0140-6736(95)91928-7.","journal-title":"Lancet"},{"key":"393_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","volume":"312","author":"WO Spitzer","year":"1996","unstructured":"Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD: Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ. 1996, 312: 83-8.","journal-title":"BMJ"},{"key":"393_CR4","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","volume":"346","author":"KW Bloemenkamp","year":"1995","unstructured":"Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP: Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet. 1995, 346: 1593-6. 10.1016\/S0140-6736(95)91929-5.","journal-title":"Lancet"},{"key":"393_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","volume":"323","author":"JM Kemmeren","year":"2001","unstructured":"Kemmeren JM, Algra A, Grobbee DE: Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ. 2001, 323: 131-4. 10.1136\/bmj.323.7305.131.","journal-title":"BMJ"},{"key":"393_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0010-7824(01)00309-2","volume":"65","author":"LA Heinemann","year":"2002","unstructured":"Heinemann LA, Lewis MA, Assmann A, Thiel C: Case control studies on venous thromboembolism: bias due to design? A methodological study on venous thromboembolism and steroid hormone use. Contraception. 2002, 65: 207-14. 10.1016\/S0010-7824(01)00309-2.","journal-title":"Contraception"},{"key":"393_CR7","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/humupd\/5.6.746","volume":"5","author":"LA Heinemann","year":"1999","unstructured":"Heinemann LA: The changing scene: an unnecessary pill crisis. Hum Reprod Update. 1999, 5: 746-55. 10.1093\/humupd\/5.6.746.","journal-title":"Hum Reprod Update"},{"key":"393_CR8","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/humrep\/14.6.1493","volume":"14","author":"MA Lewis","year":"1999","unstructured":"Lewis MA, MacRae KD, Kuhl-Habich D, et al: The differential risk of oral contraceptives: the impact of full exposure history. Hum Repod. 1999, 14: 1493-9. 10.1093\/humrep\/14.6.1493.","journal-title":"Hum Repod"},{"key":"393_CR9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0002-9378(97)70289-8","volume":"177","author":"JP Vandenbroucke","year":"1997","unstructured":"Vandenbroucke JP, Helmerhorst FM, Bloemenkamp KW, et al: Third generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation. Am J Obstet Gynecol. 1997, 177: 887-91. 10.1016\/S0002-9378(97)70289-8.","journal-title":"Am J Obstet Gynecol"},{"key":"393_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/humupd\/5.6.681","volume":"5","author":"PG Crosignani","year":"1999","unstructured":"Crosignani PG, La Vecchia C: Concordant and discordant effects on cardiovascular risks exerted by oestrogen and progestogens in women using oral contraception and hormone replacement therapy: ESHRE Capri Workshop Group. Hum Reprod Update. 1999, 5: 681-7. 10.1093\/humupd\/5.6.681.","journal-title":"Hum Reprod Update"},{"issue":"9","key":"393_CR11","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1093\/humrep\/17.9.2307","volume":"17","author":"WO Spitzer","year":"2002","unstructured":"Spitzer WO, Faith JM, MacRae KD: Myocardial infarction and third generation oral contraceptives: aggregation of recent studies. Hum Reprod. 2002, 17 (9): 2307-14. 10.1093\/humrep\/17.9.2307.","journal-title":"Hum Reprod"},{"key":"393_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","volume":"75","author":"J Dinger","year":"2007","unstructured":"Dinger J, Heinemann AJ, Kuehl-Habich D: The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation. Contraception. 2007, 75: 344-354. 10.1016\/j.contraception.2006.12.019.","journal-title":"Contraception"},{"key":"393_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","volume":"110","author":"JD Seeger","year":"2007","unstructured":"Seeger JD, Loughlin J, Eng PM, Clifford CR, Cutone J, Walker AM: Risk of Thromboembolism in Women Taking Ethinylestradiol\/Drospirenone and Other Oral Contraceptives. Obstetrics & Gynecology. 2007, 110: 587-593.","journal-title":"Obstetrics & Gynecology"},{"key":"393_CR14","doi-asserted-by":"publisher","first-page":"b2921","DOI":"10.1136\/bmj.b2921","volume":"339","author":"A Van Hylckama Vlieg","year":"2009","unstructured":"Van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJM, Rosendaal FR: The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ. 2009, 339: b2921-10.1136\/bmj.b2921.","journal-title":"BMJ"},{"key":"393_CR15","doi-asserted-by":"publisher","first-page":"b2890","DOI":"10.1136\/bmj.b2890","volume":"339","author":"\u00d8 Lidegaard","year":"2009","unstructured":"Lidegaard \u00d8, L\u00f8kkegaard E, Svendsen AL, Agger C: Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009, 339: b2890-10.1136\/bmj.b2890.","journal-title":"BMJ"},{"key":"393_CR16","first-page":"S114","volume":"18","author":"JC Dinger","year":"2009","unstructured":"Dinger JC, Voigt K, Moehner S: Case-control study: use of oral contraceptives containing dienogest and risk of venous thromboembolism. Pharmacoepidemiol Drug Saf. 2009, 18: S114-","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"393_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1783\/147118909789587385","volume":"35","author":"J Dinger","year":"2009","unstructured":"Dinger J: Oral contraceptives and venous thromboembolism: old questions revisited. J Fam Plann Reprod Health Care. 2009, 35: 211-213. 10.1783\/147118909789587385.","journal-title":"J Fam Plann Reprod Health Care"},{"key":"393_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.contraception.2008.02.019","volume":"78","author":"C Klipping","year":"2008","unstructured":"Klipping C, Duijkers I, Trummer D, Marr J: Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24\/4 regimen. Contraception. 2008, 78: 16-25. 10.1016\/j.contraception.2008.02.019.","journal-title":"Contraception"},{"key":"393_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","volume":"62","author":"R Krattenmacher","year":"2000","unstructured":"Krattenmacher R: Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception. 2000, 62: 29-38. 10.1016\/S0010-7824(00)00133-5.","journal-title":"Contraception"},{"key":"393_CR20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/oxfordjournals.aje.a115939","volume":"133","author":"M Susser","year":"1991","unstructured":"Susser M: What is a cause and how do we know one? A grammar for pragmatic epidemiology. Am J Epidemiol. 1991, 133: 635-48.","journal-title":"Am J Epidemiol"},{"key":"393_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/oxfordjournals.aje.a010135","volume":"151","author":"S Shapiro","year":"2000","unstructured":"Shapiro S: Bias in the evaluation of low-magnitude associations: an empirical perspective. Am J Epidemiol. 2000, 151: 939-945.","journal-title":"Am J Epidemiol"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2288-9-77\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-9-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-9-77","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2288-9-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T22:51:48Z","timestamp":1548197508000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/1471-2288-9-77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,18]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["393"],"URL":"https:\/\/doi.org\/10.1186\/1471-2288-9-77","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,18]]},"article-number":"77"}}